A significant increase in NIX expression was observed in intracerebral hemorrhage and ischemia/reperfusion brain injuries, suggesting that overexpression of NIX could serve as a promising therapeutic target in hemorrhagic and ischemic stroke [81]. This evidence concerns the gene BNIP3L and ischemic stroke.